Last reviewed · How we verify
Whole Body PET Baseline with 11C Rolipram — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Whole Body PET Baseline with 11C Rolipram (Whole Body PET Baseline with 11C Rolipram) — National Institute of Mental Health (NIMH).
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Whole Body PET Baseline with 11C Rolipram TARGET | Whole Body PET Baseline with 11C Rolipram | National Institute of Mental Health (NIMH) | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Whole Body PET Baseline with 11C Rolipram CI watch — RSS
- Whole Body PET Baseline with 11C Rolipram CI watch — Atom
- Whole Body PET Baseline with 11C Rolipram CI watch — JSON
- Whole Body PET Baseline with 11C Rolipram alone — RSS
Cite this brief
Drug Landscape (2026). Whole Body PET Baseline with 11C Rolipram — Competitive Intelligence Brief. https://druglandscape.com/ci/whole-body-pet-baseline-with-11c-rolipram. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab